Tokyo, March 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060906) titled 'Explaration of the association between genetic abnormalities and clinicopathological findings in follicular lymphoma' on March 13.
Study Type:
Observational
Primary Sponsor:
Institute - Nagoya University
Condition:
Condition - Follicular lymphoma
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To identify clinicopathological findings associated with genetic abnormalities in follicular lymphoma
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients diagnosed with follicular lymphoma between January 1, 2000, and August 31, 2022, at Nagoya University Hospital or at collaborating institutions that contributed only existing samples and clinical information.
Key exclusion criteria - None
Target Size - 300
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2022 Year 10 Month 28 Day
Date of IRB - 2022 Year 12 Month 28 Day
Anticipated trial start date - 2023 Year 03 Month 20 Day
Last follow-up date - 2026 Year 03 Month 20 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069575
Disclaimer: Curated by HT Syndication.
